Aclidinium Bromide Oral Inhalation (Tudorza Pressair) Drug Information - Indications, Dosage, Side Effects and Precautions | Medindia:
Aclidinium Bromide Oral Inhalation generic is an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).
http://www.medindia.net/doctors/drug_information/aclidinium_bromide_oral_inhalation.htm
Aclidinium Bromide Oral Inhalation generic is an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).
http://www.medindia.net/doctors/drug_information/aclidinium_bromide_oral_inhalation.htm
The global inhalation and nasal spray generic drugs market is estimated to reach US$ 34.2 Billion by 2021, growing at a CAGR of 6.8% from 2017 to 2021. Market by indication (allergic rhinitis, asthma, COPD, etc.), therapeutic drug classes (antihistamines, bronchodilators – albuterol, epinephrine; combination drugs – Azelastine (benzalkonium chloride), Formoterol (budesonide), Salmeterol (fluticasone); Corticosteroids – beclomethasone, budesonide, flunisolide, fluticasone; decongestant sprays – phenylephrine and oxymetazoline hydrochlorides).
ReplyDeletehttps://www.ihealthcareanalyst.com/report/inhalation-nasal-spray-generic-drugs-market/